| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000040763 |
| Receipt No. | R000046549 |
| Scientific Title | Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer |
| Date of disclosure of the study information | 2020/06/15 |
| Last modified on | 2020/06/16 (Ver. 5) |
| Basic information | ||
| Public title | Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer | |
| Acronym | Oncologic outcome of Lap-CME with D3 for T3/T4a colorectal cancer | |
| Scientific Title | Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer | |
| Scientific Title:Acronym | Oncologic outcome of Lap-CME with D3 for T3/T4a colorectal cancer | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Oncologic outcome of Laparoscopic CME with D3 |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 5-year-recurrence free survival |
| Key secondary outcomes | 5-year overall survival |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | T3/T4a colorectal cancer
R0 resection |
|||
| Key exclusion criteria | synchronous malignancies, emergency surgery, appendiceal tumor, familial tumor (familial adenomatous polyposis or lynch syndrome), inflammatory bowel disease,neuroendocrine tumor, and D2 lymph node dissection | |||
| Target sample size | 1200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Cancer Institute Hospital of the Japanese Foundation for Cancer Research | ||||||
| Division name | Gastroenterological Surgery | ||||||
| Zip code | 135-8550 | ||||||
| Address | 3-8-31 Ariake, Koto-ku, Tokyo, Japan | ||||||
| TEL | +81-3-3520-0111 | ||||||
| tkonishi-tky@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Cancer Institute Hospital of the Japanese Foundation for Cancer Research | ||||||
| Division name | Gastroenterological Surgery | ||||||
| Zip code | 135-8550 | ||||||
| Address | 3-8-31 Ariake, Koto-ku, Tokyo, Japan | ||||||
| TEL | +81-3-3520-0111 | ||||||
| Homepage URL | |||||||
| tetsuro.tominaga@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Cancer Institute Hospital of the Japanese Foundation for Cancer Research |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Cancer Institute Hospital of the Japanese Foundation for Cancer Research |
| Address | 3-8-31 Ariake, Koto-ku, Tokyo, Japan |
| Tel | +81-3-3520-0111 |
| tetsuro.tominaga@nagasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 1191 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | we aimed to examine the oncological safety of laparoscopic CME with D3 dissection for pT3/4a colon cancer, and to examine whether increased use of a laparoscopic approach changed the outcomes in a cohort at a comprehensive cancer center. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046549 |